Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

WD-40 can be a lifesaver around the home, but follow our tips to avoid misusing this popular product and achieve the best ...

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...